Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 7
2003 8
2004 8
2005 6
2006 3
2007 7
2008 9
2009 7
2010 14
2011 5
2012 12
2013 10
2014 12
2015 8
2016 8
2017 12
2018 15
2019 10
2020 16
2021 11
2022 4
2023 7
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

183 results

Results by year

Filters applied: . Clear all
Page 1
Effect of Mechanical Thrombectomy Without vs With Intravenous Thrombolysis on Functional Outcome Among Patients With Acute Ischemic Stroke: The SKIP Randomized Clinical Trial.
Suzuki K, Matsumaru Y, Takeuchi M, Morimoto M, Kanazawa R, Takayama Y, Kamiya Y, Shigeta K, Okubo S, Hayakawa M, Ishii N, Koguchi Y, Takigawa T, Inoue M, Naito H, Ota T, Hirano T, Kato N, Ueda T, Iguchi Y, Akaji K, Tsuruta W, Miki K, Fujimoto S, Higashida T, Iwasaki M, Aoki J, Nishiyama Y, Otsuka T, Kimura K; SKIP Study Investigators. Suzuki K, et al. Among authors: nishiyama y. JAMA. 2021 Jan 19;325(3):244-253. doi: 10.1001/jama.2020.23522. JAMA. 2021. PMID: 33464334 Free PMC article. Clinical Trial.
Dual Antiplatelet Therapy With Cilostazol for Secondary Prevention in Lacunar Stroke: Subanalysis of the CSPS.com Trial.
Nishiyama Y, Kimura K, Otsuka T, Toyoda K, Uchiyama S, Hoshino H, Sakai N, Okada Y, Origasa H, Naritomi H, Houkin K, Yamaguchi K, Minematsu K, Matsumoto M, Tominaga T, Tomimoto H, Terayama Y, Yasuda S, Yamaguchi T; CSPS.com Trial Investigators. Nishiyama Y, et al. Stroke. 2023 Mar;54(3):697-705. doi: 10.1161/STROKEAHA.122.039900. Epub 2023 Feb 3. Stroke. 2023. PMID: 36734235 Clinical Trial.
Hemorrhagic Wallenberg syndrome.
Ueda M, Nishiyama Y, Abe A, Katayama Y. Ueda M, et al. Among authors: nishiyama y. Intern Med. 2013;52(20):2383-4. doi: 10.2169/internalmedicine.52.1141. Intern Med. 2013. PMID: 24126409 Free article. No abstract available.
Antibodies as defensive enzymes.
Paul S, Nishiyama Y, Planque S, Karle S, Taguchi H, Hanson C, Weksler ME. Paul S, et al. Among authors: nishiyama y. Springer Semin Immunopathol. 2005 Mar;26(4):485-503. doi: 10.1007/s00281-004-0191-1. Epub 2005 Jan 5. Springer Semin Immunopathol. 2005. PMID: 15633014 Review.
[Post-stroke depression].
Katayama Y, Usuda K, Nishiyama Y, Katsura K. Katayama Y, et al. Among authors: nishiyama y. Nihon Ronen Igakkai Zasshi. 2003 Mar;40(2):127-9. doi: 10.3143/geriatrics.40.127. Nihon Ronen Igakkai Zasshi. 2003. PMID: 12708044 Free article. Japanese.
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source.
Diener HC, Sacco RL, Easton JD, Granger CB, Bernstein RA, Uchiyama S, Kreuzer J, Cronin L, Cotton D, Grauer C, Brueckmann M, Chernyatina M, Donnan G, Ferro JM, Grond M, Kallmünzer B, Krupinski J, Lee BC, Lemmens R, Masjuan J, Odinak M, Saver JL, Schellinger PD, Toni D, Toyoda K; RE-SPECT ESUS Steering Committee and Investigators. Diener HC, et al. N Engl J Med. 2019 May 16;380(20):1906-1917. doi: 10.1056/NEJMoa1813959. N Engl J Med. 2019. PMID: 31091372 Clinical Trial.
Catalytic antibodies and their applications.
Hanson CV, Nishiyama Y, Paul S. Hanson CV, et al. Among authors: nishiyama y. Curr Opin Biotechnol. 2005 Dec;16(6):631-6. doi: 10.1016/j.copbio.2005.10.003. Epub 2005 Oct 21. Curr Opin Biotechnol. 2005. PMID: 16243512 Review.
Theory of proteolytic antibody occurrence.
Paul S, Nishiyama Y, Planque S, Taguchi H. Paul S, et al. Among authors: nishiyama y. Immunol Lett. 2006 Feb 28;103(1):8-16. doi: 10.1016/j.imlet.2005.10.003. Epub 2005 Oct 26. Immunol Lett. 2006. PMID: 16290203 Review.
Prospects for immunotherapeutic proteolytic antibodies.
Zhou YX, Karle S, Taguchi H, Planque S, Nishiyama Y, Paul S. Zhou YX, et al. Among authors: nishiyama y. J Immunol Methods. 2002 Nov 1;269(1-2):257-68. doi: 10.1016/s0022-1759(02)00236-3. J Immunol Methods. 2002. PMID: 12379366 Review.
183 results